Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 10/10/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–10/09/2026 Record Record Date Vuga Group Change Status Recency Days Research Attention Score Training On Self-Breast Examination Using Visual Breast Examination Materials For İlliterate Women. 07/09/2026 INTERVENTIONAL not-comparable 93.75 6.246 Improving Uroflowmetry Interpretability: Evaluating the Impact of Patient Reminder Systems 07/09/2026 INTERVENTIONAL not-comparable 93.75 6.246 The Effect Of Postpartum Therapeutıc Touch On Breastfeedıng Self-Effıcacy, Maternal Attachment, And Postpartum Depressıon In Prımıparous Women: A Randomızed Controlled Study 07/09/2026 INTERVENTIONAL not-comparable 93.75 6.246 Expression of Target in Endometriotic Lesions 07/09/2026 OBSERVATIONAL not-comparable 93.75 6.246 Innovative Ovarian Cancer Biomarker Assays 07/09/2026 OBSERVATIONAL not-comparable 93.75 6.246 Cervical Ripening Balloon, 3 Hours vs 12 Hours Placement 07/08/2026 INTERVENTIONAL not-comparable 94.75 5.246 Study of NTB-928 in R/R OC 07/08/2026 INTERVENTIONAL not-comparable 94.75 5.246 Living With Chronic Kidney Disease Without Renal Replacement Therapy: Experience of Women of Childbearing Age 07/08/2026 OBSERVATIONAL not-comparable 94.75 5.246 DETERMINANTS OF IMMUNOTHERAPY EFFICACY IN ENDOMETRIAL CANCER 07/08/2026 INTERVENTIONAL not-comparable 94.75 5.246 Environmental Exposure Assessment in High-Risk and Early-Onset Breast Cancer Care 07/08/2026 OBSERVATIONAL not-comparable 94.75 5.246 Evaluation and Outcomes of SAVI Scout MD for Localized Breast Surgery 07/07/2026 INTERVENTIONAL not-comparable 95.75 4.246 To Establish Whether Individuals With Premenstrual Dysphoric Disorder (PMDD) Demonstrate a Different Luteal-phase Sex Hormone Profile and Ratio Compared With Asymptomatic Controls. 07/07/2026 OBSERVATIONAL not-comparable 95.75 4.246 Ovarian Reserve After Laparoscopic Cystectomy for Endometriotic and Non-Endometriotic Cysts 07/07/2026 INTERVENTIONAL not-comparable 95.75 4.246 Steri-Strip Application Versus Standard Wound Closure for Cesarean Section Incisions 07/07/2026 INTERVENTIONAL not-comparable 95.75 4.246 ESPB Versus Intravenous Lidocaine for Pain After Mastopexy 07/07/2026 INTERVENTIONAL not-comparable 95.75 4.246 Breathing for Two: Inspiratory Muscle Strength Training for Supporting Healthy Blood Pressure in Pregnancy 07/07/2026 INTERVENTIONAL not-comparable 95.75 4.246 Transcutaneous Auricular Neurostimulation (tAN) for Premenstrual Dysphoric Disorder (PMDD) and Perimenopause 07/07/2026 INTERVENTIONAL not-comparable 95.75 4.246 Regional Block for Post-mastectomy Analgesia 07/06/2026 INTERVENTIONAL not-comparable 96.75 3.246 Study on the Self-Administered Use of a Specialized Kit for the Management of Sexual Pain Associated With Endometriosis 07/06/2026 INTERVENTIONAL not-comparable 96.75 3.246 Adjuvant Moderately Hypofractionated Intensity-modulated Radiotherapy for Cervical Cancer 07/06/2026 INTERVENTIONAL not-comparable 96.75 3.246 A Study to Investigate Mocertatug Rezetecan With Bevacizumab Compared With Platinum Doublet With Bevacizumab in Participants With Platinum-sensitive Ovarian Cancer (BEHOLD-Ovarian02) 07/06/2026 INTERVENTIONAL not-comparable 96.75 3.246 Effect of Participating in a Study of Causes of Pregnancy Loss on Mental Health Outcomes: A Target Trial Emulation Using the COPL Cohort and Danish National Registries 07/06/2026 INTERVENTIONAL not-comparable 96.75 3.246 The Impact of Myo-Inositol on Glycemic Control and Oxidative Stress in Gestational Diabetes Mellitus 07/06/2026 INTERVENTIONAL not-comparable 96.75 3.246 Relation Between Type of Scar Pregnancy and Number of Previous Cesarean Sections 07/06/2026 OBSERVATIONAL not-comparable 96.75 3.246 Alpha-Lipoic Acid Supplementation and IVF Outcomes in Women of Advanced Maternal Age 07/06/2026 INTERVENTIONAL not-comparable 96.75 3.246 Upper vs Lower Extremity BP in Spinal Cesarean Using ClearSight 07/06/2026 OBSERVATIONAL not-comparable 96.75 3.246 Cervical Ripening Balloon Compared With Vaginal Misoprostol for Cervical Ripening in Obese Woman at Term 07/06/2026 INTERVENTIONAL not-comparable 96.75 3.246 Evaluation of Facial and Neck Skin Laxity With SofWave Treatment in Adults Initiating Tirzepatide for Weight Loss 07/06/2026 INTERVENTIONAL not-comparable 96.75 3.246 Specimen and Data Study for Ovarian Cancer Early Detection and Prevention 01/27/2003 OBSERVATIONAL not-comparable 8,657.75 0 Nurses' Health Study (Cardiovascular Component) 05/26/2000 OBSERVATIONAL not-comparable 9,633.75 0 Comparison of Fulvestrant (FASLODEX™) 250 mg and 500 mg in Postmenopausal Women With Oestrogen Receptor Positive Advanced Breast Cancer Progressing or Relapsing After Previous Endocrine Therapy. 12/14/2004 INTERVENTIONAL not-comparable 7,970.75 0 Gestational Sulfadoxine-pyrimethamine and Azithromycin Treatment to Prevent Preterm Birth 08/17/2005 INTERVENTIONAL not-comparable 7,724.75 0 Accelerated Partial Breast Irradiation Following Lumpectomy for Breast Cancer 09/16/2005 INTERVENTIONAL not-comparable 7,694.75 0 Cervix: Hypoxia, Interstitial Fluid Pressure and GSH Levels 09/16/2005 INTERVENTIONAL not-comparable 7,694.75 0 Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS) 09/20/2005 OBSERVATIONAL not-comparable 7,690.75 0 High Risk Breast Clinic: Protocol for Women at Increased Risk for Developing Breast Cancer 02/13/2006 OBSERVATIONAL not-comparable 7,544.75 0 Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial) 04/03/2006 INTERVENTIONAL not-comparable 7,495.75 0 Effects of Oncological Treatment During Pregnancy on Mother and Child 05/26/2006 OBSERVATIONAL not-comparable 7,442.75 0 Using Diagnostic Tools to Stage Breast Cancer 08/23/2006 INTERVENTIONAL not-comparable 7,353.75 0 Xenogeneic HER2/Neu DNA Immunization for Patients With Metastatic and High Risk Breast Cancer: A Phase I Study to Assess Safety and Immunogenicity 10/30/2006 INTERVENTIONAL not-comparable 7,285.75 0 Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant People. 11/29/2006 OBSERVATIONAL not-comparable 7,255.75 0 Combination Chemotherapy With or Without Fluorouracil and/or Pegfilgrastim in Treating Women With Node-Positive Breast Cancer 02/12/2007 INTERVENTIONAL not-comparable 7,180.75 0 Ultrasound Imaging, Spectroscopy and Ultrasound Imaging of Vascular Blood Flow as Early Indicators of Breast Cancer Response to Neoadjuvant Treatment. 02/21/2007 OBSERVATIONAL not-comparable 7,171.75 0 Safety Follow-up Study in Subjects With Silicone Gel-filled Breast Implants as Compared Both to Saline-filled Breast Implants and to National Norms 03/05/2007 OBSERVATIONAL not-comparable 7,159.75 0 Impact of Diet and Exercise Activity on Pregnancy Outcomes 06/14/2007 INTERVENTIONAL not-comparable 7,058.75 0 Data Collection for Patients With Low Grade Ovarian or Peritoneal Tumors 06/20/2007 OBSERVATIONAL not-comparable 7,052.75 0 Risk Factors for Endometrial Cancer in Black Women 08/09/2007 OBSERVATIONAL not-comparable 7,002.75 0 Depression Treatment and Screening in Ovarian Cancer Patients 08/13/2007 INTERVENTIONAL not-comparable 6,998.75 0 Use of CA125 and Complementary Biomarkers for the Early Detection of Ovarian Cancer in Low Risk Women 10/04/2007 INTERVENTIONAL not-comparable 6,946.75 0 Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer 11/30/2007 INTERVENTIONAL not-comparable 6,889.75 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 10/10/2026 · upstream last modified 10/10/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Research Attention Score using the documented compute method. · methodology